The Associations Between the TyG Index and the Risk of Cancer—A Systematic Review and Meta‐Analysis
Cancer Medicine · 2025-10 · 14 (19)
DOI: 10.1002/cam4.71232 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Medicine, online erschienen am 02.10.2025. Verfasst von Hongyu Li und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Neoplasms, Insulin Resistance, Triglycerides, Blood Glucose. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Sichuan, Medical Youth Innovation Research Project of Sichuan Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
The triglyceride glucose (TyG) index, a simple and reliable surrogate marker of insulin resistance (IR), has garnered increasing attention in metabolic research. Although IR is mechanistically linked to carcinogenesis through multiple pathways, including chronic inflammation, hyperinsulinemia‐driven pro‐mitogenic signaling, and altered adipokine secretion, the specific utility of the TyG index for cancer risk assessment remains unclear. This systematic review examines whether the TyG index shows consistent associations across cancer types and holds value as an independent risk predictor beyond established metabolic syndrome components.
Methods
We systematically searched PubMed, Embase, and Web of Science databases from 2008 (the year the TyG index was established as an IR marker) to December 31, 2024, for studies on the TyG index‐cancer association. Cohort, cross‐sectional, and case–control studies were included. Using meta‐analysis, we pooled effect sizes and conducted subgroup analyses by gender, region, population source, and study design. Trial sequential analysis (TSA) evaluated evidence reliability.
Results
This meta‐analysis incorporated a total of 20 eligible studies. Our findings demonstrated that elevated TyG index levels were significantly associated with increased risks of various malignancies, including digestive system cancers (OR: 1.22, 95% CI 1.13–1.31), urogenital system cancers (OR: 2.04, 95% CI 1.53–2.71), and breast cancer (OR: 1.64, 95% CI 1.49–1.80) when compared to lower TyG index levels. These associations remained consistent across all pre‐specified subgroup analyses stratified by study characteristics. Furthermore, TSA confirmed sufficient statistical power for definitive conclusions.
Conclusions
The consistent observed association between elevated TyG index and increased cancer risk highlights its potential as a candidate biomarker for further investigation. While these findings support the biological plausibility of insulin resistance in oncogenesis, current evidence—partially derived from observational studies—cannot establish causality or direct clinical utility. Future research should prioritize: (1) prospective validation of TyG index thresholds for cancer risk prediction, (2) mechanistic studies elucidating its role in tumor biology, and (3) assessment of its incremental value to existing risk stratification tools.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology and Biostatistics, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
- Health Promotion and Food Nutrition & Safety Key Laboratory of Sichuan Province, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
- Department of Pediatric Pulmonology and Immunology, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
- Sichuan Birth Defects Clinical Research Center, West China Second University Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Xin Wang
Förderung
- Natural Science Foundation of Sichuan
- Medical Youth Innovation Research Project of Sichuan Province
- National Natural Science Foundation of China
- "From 0 to 1" Innovation Project, Sichuan University
- The research start-up fund for the introduction of talents of Sichuan University
- Sichuan Provincial Science and Technology Department 2023 Central Guide Local Project
- The Sichuan Tianfu Emei Plan for Young Talents
- The Sichuan Health Commission's Popularization and Application Project
Zitieren
APA
Li, H., Chen, Z., Jiang, G., Yu, W., Luo, J., Li, S., Xie, L., Bai, X., Xu, Y., Jiang, Y., He, M., Mao, M., & Wang, X. (2025). The Associations Between the TyG Index and the Risk of Cancer—A Systematic Review and Meta‐Analysis. Cancer Medicine, 14(19). https://doi.org/10.1002/cam4.71232
Vancouver
Li H, Chen Z, Jiang G, Yu W, Luo J, Li S, et al. The Associations Between the TyG Index and the Risk of Cancer—A Systematic Review and Meta‐Analysis. Cancer Medicine. 2025;14(19). doi:10.1002/cam4.71232
BibTeX
@article{Li2025,
author = {Li, Hongyu and Chen, Zijie and Jiang, Guoheng and Yu, Wenqian and Luo, Jing and Li, Shiyi and Xie, Linjun and Bai, Xuan and Xu, Yiting and Jiang, Yi and He, Menglin and Mao, Min and Wang, Xin},
title = {The Associations Between the TyG Index and the Risk of Cancer—A Systematic Review and Meta‐Analysis},
journal = {Cancer Medicine},
year = {2025},
volume = {14},
number = {19},
doi = {10.1002/cam4.71232}
}
EUVIMED